Discovery of frequent homozygous deletions in chromosome 3p21.3 LUCA and AP20 regions in renal, lung and breast carcinomas

被引:83
|
作者
Senchenko, VN
Liu, J
Loginov, W
Bazov, I
Angeloni, D
Seryogin, Y
Ermilova, V
Kazubskaya, T
Garkavtseva, R
Zabarovska, VI
Kashuba, VI
Kisselev, LL
Minna, JD
Lerman, MI
Klein, G
Braga, EA
Zabarovsky, ER [1 ]
机构
[1] Karolinska Inst, Ctr Microbiol & Tumor Biol, Ctr Genom & Bioinformat, S-17177 Stockholm, Sweden
[2] Russian Acad Sci, Ctr Bioengn, Moscow 117312, Russia
[3] Russian State Genet Ctr, Moscow 117545, Russia
[4] Natl Canc Inst, Immunobiol Lab, Canc Causing Genes Sect, Ctr Canc Res, Frederick, MD 21702 USA
[5] Russian Acad Med Sci, Blokhin Canc Res Ctr, Moscow 115478, Russia
[6] Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow 119991, Russia
[7] Univ Texas, SW Med Ctr, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA
关键词
breast cancer; human chromosome 3p; lung cancer; renal carcinoma; tumour suppressor genes; quantitative real-time PCR;
D O I
10.1038/sj.onc.1207760
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We searched for chromosome 3p homo- and hemizygous losses in 23 lung cancer cell lines, 53 renal cell and 22 breast carcinoma biopsies using 31 microsatellite markers located in frequently deleted 3p regions. In addition, two sequence-tagged site markers (NLJ-003 and NL3-001) located in the Alu-PCR clone 20 region (AP20) and lung cancer (LUCA) regions, respectively, were used for quantitative real-time PCR (QPCR). We found frequent (10-18%) homozygous deletions (HDs) in both 3p2l.3 regions in the biopsies and lung cancer cell lines. In addition, we discovered that amplification of 3p is a very common (15-42.5%) event in these cancers and probably in other epithelial malignancies. QPCR showed that aberrations of either NLJ-003 or NL3-001 were detected in more than 90% of all studied cases. HDs were frequently detected simultaneously both in NLJ-003 or NL3-001 loci in the same tumour (P < 3-10(-7)). This observation suggests that tumour suppressor genes (TSG) in these regions could have a synergistic effect. The exceptionally high frequency of chromosome aberrations in NLJ-003 and NL3-001 loci suggests that multiple TSG(s) involved in different malignancies are located very near to these markers. Precise mapping of 15 independent HDs in the LUCA region allowed us to establish the smallest HD region in 3p21.3C located between D3S1568 (CACNA2D2 gene) and D3S4604 (SEMA3F gene). This region contains 17 genes. Mapping of 19 HDs in the AP20 region resulted in the localization of the minimal region to the interval flanked by D3S1298 and D3S3623 markers. Only four genes were discovered in this interval, namely, APRG1, ITGA9, HYA22 and VILL.
引用
收藏
页码:5719 / 5728
页数:10
相关论文
共 14 条
  • [1] Discovery of frequent homozygous deletions in chromosome 3p21.3 LUCA and AP20 regions in renal, lung and breast carcinomas
    Vera N Senchenko
    Jian Liu
    Witaly Loginov
    Igor Bazov
    Debora Angeloni
    Yury Seryogin
    Valeria Ermilova
    Tatiana Kazubskaya
    Raisa Garkavtseva
    Veronika I Zabarovska
    Vladimir I Kashuba
    Lev L Kisselev
    John D Minna
    Michael I Lerman
    George Klein
    Eleonora A Braga
    Eugene R Zabarovsky
    [J]. Oncogene, 2004, 23 : 5719 - 5728
  • [2] TUMOR SUPPRESSOR GENES IN 3P21.3 LUCA AND AP20 REGIONS: A NEW MODEL FOR THE DEVELOPMENT OF MAJOR EPITHELIAL MALIGNANCIES
    Zabarovsky, Eugene
    Kashuba, Vladimir
    Li, Jingfeng
    Protopopov, Alexey
    Wang, Fuli
    Malyukova, Alena
    Senchenko, Vera
    Zabarovska, Veronika
    Muravenko, Olga
    Zelenin, Alexander
    Kadyrova, E.
    Braga, Eleonora
    Kisselev, Lev
    Lerman, Michael I.
    Klein, George
    [J]. ANTICANCER RESEARCH, 2004, 24 (5D) : 3676 - 3677
  • [3] Deletions at the chromosome 3 common eliminated region 1 on 3p21.3 in human breast tumors
    ThE Petursdottir
    U Thorsteinsdottir
    JG Jonasson
    PH Moller
    C Huiping
    J Bjornsson
    V Egilsson
    S Imreh
    S Ingvarsson
    [J]. Breast Cancer Research, 7
  • [4] Deletions at the chromosome 3 common eliminated region 1 on 3p21.3 in human breast tumors
    Petursdottir, TE
    Thorsteinsdottir, U
    Jonasson, JG
    Moller, PH
    Huiping, C
    Bjornsson, J
    Egilsson, V
    Imreh, S
    Ingvarsson, S
    [J]. BREAST CANCER RESEARCH, 2005, 7 (Suppl 2) : S38 - S38
  • [5] An integrated physical and gene map of the 3.5-Mb chromosome 3p21.3 (AP20) region implicated in major human epithelial malignancies
    Protopopov, A
    Kashuba, V
    Zabarovska, VI
    Muravenko, OV
    Lerman, MI
    Klein, G
    Zabarovsky, ER
    [J]. CANCER RESEARCH, 2003, 63 (02) : 404 - 412
  • [6] Analyses of genes from a cosmid contig at 3p21.3 covering the overlap of several homozygous deletions in small cell lung cancer cell lines
    Latif, F
    Sekido, Y
    Duh, FM
    Wei, MH
    Bader, S
    Geil, L
    Kashuba, V
    Zabarovsky, E
    Kuzmin, I
    Chen, JY
    Klein, G
    Zbar, B
    Minna, JD
    Lerman, MI
    [J]. JOURNAL OF MEDICAL GENETICS, 1997, 34 : SP59 - SP59
  • [7] FREQUENT HOMOZYGOUS DELETIONS IN LUNG-CANCER CELL-LINES DETECTED BY A DNA MARKER LOCATED AT 3P21.3-P22
    YAMAKAWA, K
    TAKAHASHI, T
    HORIO, Y
    MURATA, Y
    TAKAHASHI, E
    HIBI, K
    YOKOYAMA, S
    UEDA, R
    TAKAHASHI, T
    NAKAMURA, Y
    [J]. ONCOGENE, 1993, 8 (02) : 327 - 330
  • [8] The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: Identification and evaluation of the resident candidate tumor suppressor genes
    Lerman, MI
    Minna, JD
    [J]. CANCER RESEARCH, 2000, 60 (21) : 6116 - 6133
  • [9] HYAL1LUCA-1, a candidate tumor suppressor gene on chromosome 3p21.3, is inactivated in head and neck squamous cell carcinomas by aberrant splicing of pre-mRNA
    Frost, GI
    Mohapatra, G
    Wong, TM
    Csóka, AB
    Gray, JW
    Stern, R
    [J]. ONCOGENE, 2000, 19 (07) : 870 - 877
  • [10] HYAL1LUCA-1, a candidate tumor suppressor gene on chromosome 3p21.3, is inactivated in head and neck squamous cell carcinomas by aberrant splicing of pre-mRNA
    Gregory I Frost
    Gayatry Mohapatra
    Tim M Wong
    Antonei Benjamin Csóka
    Joe W Gray
    Robert Stern
    [J]. Oncogene, 2000, 19 : 870 - 877